Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank71
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.24
↑ 82% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-12.68
Historical baseline
PeriodValueYoY Change
2025-2.24-196.3%
2024-0.76+64.2%
2023-2.12+14.7%
2022-2.48+53.3%
2021-5.31+90.3%
2020-54.93-78.4%
2019-30.79-994.7%
2018-2.81-